Search results
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 5 days agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
US respiratory virus levels tail off to low levels
Center for Infectious Disease Research and Policy· 3 days agoThough the flu season is winding down, the CDC received 10 more reports of pediatric flu deaths, including one from a flu A/flu B coinfection.
Arkansas reports 2 more flu deaths, 14 new covid deaths for week | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 4 days agoTwo flu-related deaths were reported in Arkansas over the past week, raising this season's death toll to 121, the state Department of Health reported Wednesday. One of the deaths reported in ...
Unlocking Lifetime Flu Protection: Duke’s Innovative Vaccine Strategy
SciTechDaily· 5 days agoDuke researchers have opened a new avenue in the attack against influenza viruses by creating a...
Sensodyne-maker Haleon posts tepid sales as demand for some products cool off
AOL· 6 days agoThe maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and < ...
Allergies and climate: Pollen in Minnesota comes earlier with warmer temperatures
MPR News· 3 days agoMinnesota is now in peak tree pollen season. If you feel like your allergies have gotten worse in recent years, you are not alone. Studies have linked warming temperatures to longer and more ...
New approach could lead to universal flu vaccine
Futurity· 4 days agoResearchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion...
Experimental vaccine targets portions of the flu virus that don't change
Medical Xpress· 5 days agoThis new vaccine approach, described May 1 in the journal Science Translational Medicine, is part of a five-year-old effort to develop a longer-lasting universal flu vaccine that would be able ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 4 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter revenue is down ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 4 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.